{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-089966","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.608191+00:00","generated_at":"2026-05-31T13:29:45.425439+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Revelation Biosciences faces $7.3M judgment in LifeSci Capital lawsuit","bullets":["U.S. District Court entered summary judgment against Revelation Biosciences for ~$7.3M in unpaid banking and advisory fees plus interest.","Judgment adopted Magistrate Judge's December 2023 recommendation; company had contested fee obligation from pre-merger contracts.","Company states it has sufficient cash to satisfy the judgment and expects no immediate impact on clinical trial programs."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-089966","json":"https://secwatch.observer/filing/0000950170-24-089966.json","markdown":"https://secwatch.observer/filing/0000950170-24-089966.md","text":"https://secwatch.observer/filing/0000950170-24-089966.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/0000950170-24-089966-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/revb-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:29:45.425439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}